Znanstveni rad - Pregledni rad
A summary of current NKG2D-based CAR clinical trials
Immunotherapy Advances, 1 (2021), 1; 1-8. https://doi.org/10.1093/immadv/ltab018

Curio, Sophie; Jonsson, Gustav; Marinović, Sonja

Citirajte ovaj rad

Curio, S., Jonsson, G. i Marinović, S. (2021). A summary of current NKG2D-based CAR clinical trials. Immunotherapy Advances, 1. (1), 1-8. doi: 10.1093/immadv/ltab018

Curio, Sophie, et al. "A summary of current NKG2D-based CAR clinical trials." Immunotherapy Advances, vol. 1, br. 1, 2021, str. 1-8. https://doi.org/10.1093/immadv/ltab018

Curio, Sophie, Gustav Jonsson i Sonja Marinović. "A summary of current NKG2D-based CAR clinical trials." Immunotherapy Advances 1, br. 1 (2021): 1-8. https://doi.org/10.1093/immadv/ltab018

Curio, S., Jonsson, G. i Marinović, S. (2021) 'A summary of current NKG2D-based CAR clinical trials', Immunotherapy Advances, 1(1), str. 1-8. doi: 10.1093/immadv/ltab018

Curio S, Jonsson G, Marinović S. A summary of current NKG2D-based CAR clinical trials. Immunotherapy Advances [Internet]. 01.01.2021. [pristupljeno 20.07.2024.];1(1):1-8. doi: 10.1093/immadv/ltab018

S. Curio, G. Jonsson i S. Marinović, "A summary of current NKG2D-based CAR clinical trials", Immunotherapy Advances, vol. 1, br. 1, str. 1-8, Siječanj 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:286089. [Citirano: 20.07.2024.]